Indeed, several splice factors including BUD31, SF3B1 and SRSF1 [85] are known to be gene targets of the oncoprotein MYC and inhibition or knockdown of those in MYC hyperactivated breast cancer cells impairs tumorigenesis [86]. This evidence concerns the gene MYC and breast cancer.